Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cytoskeleton is a complex network of protein filaments that provide structural integrity and spatial organization within prokaryotic cells (Erickson, 1997, PubMed: 9298640). It includes essential proteins such as FtsZ, a tubulin homolog that forms the contractile Z-ring during cell division, and MreB, an actin homolog that directs cell wall synthesis to maintain cell shape (van den Ent et al., 2001, Nature). Other components like ParM and MinCDE are involved in plasmid segregation and the precise positioning of the division machinery (Gitai, 2005, PubMed: 16103211). These proteins are vital for bacterial survival and reproduction, making them promising targets for the development of next-generation antibiotics. Small molecules targeting the bacterial cytoskeleton, such as PC190723 and A22, act by disrupting the polymerization and dynamic stability of these filaments (Haydon et al., 2008, Science). Such interference leads to catastrophic failures in cell division and morphology, ultimately resulting in bacterial cell death. Because bacterial cytoskeletal proteins are distinct from eukaryotic actin and tubulin, they offer the potential for high selectivity and reduced side effects in human hosts. Research in this area is particularly focused on overcoming multi-drug resistance in pathogens like Staphylococcus aureus and Escherichia coli.
Inhibition of protein polymerization and filament assembly, disruption of the Z-ring formation during cytokinesis, and interference with cell wall synthesis coordination.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cytoskeleton and associated structural proteins.